Trending

Australia

Imugene HER2 vaccine hits target in stomach cancer trial

Imugene HER2 vaccine hits target in stomach cancer trial

A peptide vaccine developed by Australia’s Imugene has reduced tumour size in around half of patients with HER2-positive

X

Imugene HER2 vaccine hits target in stomach cancer trial

https://pharmaphorum.com/news/imugene-her2-vaccine-hits-target-in-stomach-cancer-trial/

Regulatory timelines in the Asia-Pacific

Regulatory timelines in the Asia-Pacific

Snapshot of clinical trial application processes in the region.

X

Regulatory timelines in the Asia-Pacific

https://pharmaphorum.com/views-and-analysis/regulatory-timelines-asia-pacific/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com